Phosphorus Diagnostics
1140 Broadway
New York
New York
10011
United States
Tel: 855-746-7423
Website: http://phosphorus.com/
About Phosphorus Diagnostics
Phosphorus is a genomic health company with the vision to create a world where every healthcare decision is optimized with genomics. Headquartered in New York City, Phosphorus Diagnostics offers clinical genetic tests in a range of clinical areas through its CLIA-certified laboratory. Phosphorus also develops powerful data-driven software that enables labs around the world to deliver the most advanced genetic tests. The company's active research and development program has an initial focus on decoding the genetic causes of infertility and inherited cardiovascular disease. With a team of experts in computational biology and computer science, Phosphorus is building a data network that will help providers, researchers and patients around the world better understand and harness the power of the human genome.YEAR FOUNDED:
2014
LEADERSHIP:
Co-Founder & CEO: Alexs Bisignano Co-Founder & Director: Santiago Munne, Ph.D.
CAREER:
Please click here for Phosphorus' job opportunities.
9 articles about Phosphorus Diagnostics
-
Mikrogen and Phosphorus Announce Partnership to Provide Holistic, Preventative Genetic Insights to Reproductive Health Services in Turkey.
2/24/2022
Phosphorus, a leading preventative genomics company, announced that it had entered into a partnership with Mikrogen, a genetic diagnosis laboratory focused on reproductive genetics, to offer GeneCompass, the Phosphorus holistic, medical-grade genetic test, to Mikrogen customers throughout the Middle East and Europe.
-
Phosphorus Announces FDA Approval Of At-Home Saliva Test For COVID-19
6/8/2020
Tests Facilitate Safe Clinical Care and Employer Health Programs, Also Available to General Public Through Web Order At-Home Saliva Test Gains Federal Approval After Rigorous Round of Validation Studies
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 8, 2020.
-
Phosphorus Receives Approval to Market PhosphorusONE from New York State Department of Health
3/4/2019
PhosphorusONE is the third test approved for Phosphorus in the state in the past three months.
-
Phosphorus expands executive team to scale growing business
7/30/2018
Phosphorus, a leader in diagnostic and bioinformatic solutions for clinical Next Generation Sequencing (NGS), announced today that Mark McDonough, most recently chief executive officer of CombiMatrix, has been named chief business officer.
-
Phosphorus Announces Launch of Genetic Testing SaaS Platform, Elements
10/17/2017
Phosphorus announced today the formal launch of its Elements software suite to power diagnostic genetic testing for laboratories, hospital networks, and other health centers.
-
Phosphorus Diagnostics Launches Diagnostic Ophthalmology And Drug Response Genetic Tests
9/14/2017
-
Phosphorus Diagnostics Launches Diagnostic Genetic Tests for Hereditary Cancers
6/5/2017
-
Phosphorus Diagnostics Launches Genetic Tests For Inherited Cardiology Diseases Associated With Sudden Death And High Cholesterol
3/17/2017